Article
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis
2024-04-30
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is a devastating pulmonary disease with no curative treatment other than lung transplantation. IPF results from maladaptive responses to lung epithelial injury, but the underlying mechanisms remain unclear. Here, we show that deficiency in the innate immune receptor, toll-like receptor 5 (TLR5), is associated with IPF in humans and with increased susceptibility to epithelial inj...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f86cd5ce-7e3a-5b5e-aa9f-4c2e722af1e8
- DOI
- 10.1101/2024.04.30.591719
